Analysis of 76 patients with urticaria and angioedema induced by non-steroidal anti-inflammatory drugs (NSAIDS) in Japan

Japanese Journal of Allergology

Volumn 60, Issue 6, 2011, Pages 699-707

  Moriya, Maki ^a   Aihara, Michiko ^a   Hirota, Rie ^a   Hirata, Yuko ^a   Ikinaga, Naoko ^a   Takamura, Naoko ^a   Kunimi, Yuko ^a   Uchida, Takahisa ^a   Ikezawa, Zenro ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Angioedema; Aspirin; NSAIDs intolerance; Urticaria

Indexed keywords

ACETYLSALICYLIC ACID; CELECOXIB; MELOXICAM; TIARAMIDE;

ANGIONEUROTIC EDEMA; ARTICLE; ASTHMA; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; MEDICAL LITERATURE; PATHOGENESIS; PRICK TEST; RETROSPECTIVE STUDY; URTICARIA;

ADOLESCENT; ADULT; AGED; ANGIOEDEMA; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHILD; CHILD, PRESCHOOL; DRUG HYPERSENSITIVITY; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; URTICARIA;

EID: 79960826674     PISSN: 00214884     EISSN: 13477935     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Gollapudi RR, Teirstein PS, Steavenson DD, Simon RA. Aspirin sensitivity: implications for patients with coronary artery disease. JAMA 2004; 292: 3017-23. (Pubitemid 39665304)
2. Kowalski ML. Aspirin-sensitive rhinosinusitis and asthma. Clin Allergy Immunol 2007; 19: 147-75.
3. Stevenson DD, Andrew Szczeklik A. Clinical and pathologic perspectives on aspirin sensitivity and asthma. J Allergy ClinImmunol 2006; 118: 773-86. (Pubitemid 44515109)
4. Szczeklik A, Nizankowska E, Duplaga M. Natural history of aspirin-induced asthma. AIANE investigators. European Network on aspirin-induced asthma. Eur Respir J 2000; 16: 432-6.
5. Berges-Gimeno MP, Simon RA, Stevenson DD. The natural history and clinical characteristics of aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol 2002; 89: 474-8. (Pubitemid 36187990)
6. Inomata N, Osuna H, Yamaguchi J, Onoda M, Takeshita Y, Chiba Y, et al. Safety of selective cyclooxygenage-2 inhibitors and a basic non-steroidal anti-inflammatory drug (NSAIDs) in Japanese patients with NSAIDsinduced urticaria and/or angioedema: Comparison of meloxicam, etodolac and tiaramide. J Dermatol 2007; 34: 172-7. (Pubitemid 46213950)
7. Higashi N, Taniguchi M, Mita H, Higashi A, Akiyama K. Aspirin-induced urticaria and angioedema but not bronchoconstriction, associated with cysteinylleukotriene overproduction in 2 patients with ashma. J Allergy ClinImmunol 2002; 110: 666-7.
8. Szczeklik A, Sanak M. The role of COX-1 and COX-2 in asthma pathogenesis and its significance in the use of selective inhibitors. Clin Exp Allergy 2002; 32: 339-42. (Pubitemid 34415629)
9. Stevenson DD, Simon RA. Lack of cross-reactivity between rofecoxib and aspirin in aspirin-sensitive patients with asthma. J Allergy ClinImmunol 2001; 108: 47-51. (Pubitemid 32662231)
10. Gyllfors P, Bochenek G, Overholt J, Drupka D, Kumlin M, Sheller J, et al. Biochemical and clinical evidence that aspirin-intolerant asthmatic subjects tolerate the cyclooxygenase 2-selective analgetic drug celecoxib. J Allergy ClinImmunol 2003; 111: 1116-21. (Pubitemid 36570875)
11. Szczeklik A, Stevenson DD. Aspirin-induced asthma: Advances in pathogenesis, diagnosis, and management. J Allergy ClinImmunol 2003; 111: 913-21. (Pubitemid 36570845)
12. Szczeklik A, Sanak M. The broken balance in aspirin hypersensitivity. Eur J Pharmacol 2006; 533: 145-55.
13. 4 synthase promoter polymorphism in Japanese patients with aspirininduced asthma. J Allergy ClinImmunol 2002; 109: 936-42. (Pubitemid 34634302)
14. 4 excretion (hyperleukotrienuria): Involvement of chronic hyperplasticrhinosinusitis with nasal polyposis. J Allergy ClinImmunol 2004; 113: 277-83. (Pubitemid 38210550)
15. Sanak M, Simon HU, Szczeklik A. Leukotriene C4 synthase promoter polymorphism and risk of aspirin-induced asthma. Lancet 1997; 350: 1599-600. (Pubitemid 28036609)
16. Mastalerz L, Setkowicz M, Sanak M, Szczeklik A. Hypersensitivity to aspirin: Common eicosanoid alterations in urticaria and asthma. J Allergy ClinImmunol 2004; 113: 771-5.
17. Setkowicz M, Mastalerz L, Podolec-Rubis M, Sanak M, Szczeklik A. Clinical course and urinary eicosanoids in patients with aspirininduced urticaria followed up for 4 years. J Allergy ClinImmunol 2009; 123: 174-8.
18. Ozlem G, Omur A, Zeynep M, Yavuz SD, Sevim B. Safety of meloxicam in patients with aspirin/non-steroidal anti-inflammatory drug-induced urticaria and angioedema. J Dermatol 2010; 37: 973-9.
19. Nettis E, Paola RD, Ferrannini A, Tursi A. Meloxicam in hypersensitivity to NSAIDs. Allergy 2001; 56: 803-4. (Pubitemid 32681726)
20. Domingo MV, Marchuet MC, Culla MD, Joanpere RS, Guadano EM. Meloxicam tolerance in hypersensitivity to nonsteroidal antiinflammatory drugs. J Investig Allergol ClinImmunol 2006; 16: 364-6.
21. Sanchez-Borges M, Capriles-Hulett A, Caballero-Fonseca F, Perez CR. Tolerability to new COX-2 inhibitors in NSAIDs-sensitive patients with cutaneous reactions. Ann Allergy Asthma Immunol 2001; 87: 201-4.
22. Sanchez-Borges M, Caballero-Fonseca F, Capriles-Hulett A. Safety of etoricoxib, a new cyclooxygenase 2 inhibitor, in patients with nonsteroidalanti-inflammatory drug-induced urticaria and angioedema. Ann Allergy Asthma Immunol 2005; 95: 154-8. (Pubitemid 41170176)
23. Hogaboam CM, Bissonnette EY, Chin BC, Befus AD, Wallace JL. Prostaglandins inhibit inflammatory mediator release from rat mast cells. Gastroenterology 1993; 104: 122-9. (Pubitemid 23040014)
24. Aihara M, Yamakawa Y, Chiba Y, Okajima M, Takahashi S, Ikezawa Z. A case of fooddepentent exercise-induced anaphylaxis induced by exercise after administration of wheat and acetylsalicylic acid. Environ Dermatol 1999; 6: 247-53.
25. Morita E, Yamamura Y, Mihara S, Kameyoshi Y, Yamamoto S. Food-dependent exercize-induced anaphylaxis: a report of two cases and determination of wheat-γ-gliadin as the presumptive allergen. Br J Dermatol 2000; 143: 1059-63.
26. Matsukura S, Aihara M, Sugawara M, Kunimi Y, Matsuki M, Inoue Y, et al. Two cases of wheat-dependent anaphylaxis induced by aspirin administration but not induced by exercise. Clin Exp Dermatol 2010; 35: 233-7.